Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →Filing growth compares 2021 (522 records) with 2024 (311) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 12,342 records in scope (CR5), not by the ranked leaders only.
The dataset covers 12,342 patent families published between 2015 and 2026 across image reconstruction, gradient coil, RF coil array, accelerated acquisition and pulse sequence filings within G01R33/48, G01R33/56 and A61B5/055. Filing activity peaked in 2019 at 670 records and has since declined, with the 2022 midpoint already down to 492 — a pattern consistent with a mature rather than emerging field.
Receiving-office data shows the United States carrying the largest share of filings at 6,100, followed by Europe (EPO) at 2,307 and the WIPO PCT route at 1,177, with Japan, China and India trailing. That distribution points to the US and Europe as the primary contested jurisdictions, with PCT filings indicating deliberate multi-market strategies among the larger assignees.
Pick a task. Every answer cites the patents behind it.
Publication counts by year and by IPC subclass show where MRI-related filing activity concentrates and how it has moved since 2017.
Filings peaked at 670 in 2019 and have declined since, reaching 623 in 2017 and falling to 26 by 2026; the midpoint year 2022 sat at 492, confirming a flat-to-declining trajectory. The final two years are undercounted because publication lags filing by roughly 18 months.
G01R (electric and magnetic measurement) and A61B (diagnosis and surgery) dominate with 10,752 and 7,403 records respectively, dwarfing image processing (G06T, 1,093), geophysics-adjacent filings (G01V, 631), electrotherapy (A61N, 472), magnet hardware (H01F, 404), AI computing (G06N, 326) and material analysis (G01N, 321).
Shares are the percentage of the 12,342 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
This page is one run against one query. Ask Eureka your own question about medical imaging mri landscape and every answer comes back with the patent numbers behind it.
Try EurekaVarious methods and systems are provided for a flexible, lightweight, low-cost radio frequency (RF) coil array of a magnetic resonance imaging (MRI) system. In one example, a RF coil array for a MRI system includes a plurality of RF coils, each RF coil comprising an integrated capacitor coil loop; a plurality of coupling electronics units each coupled to a respective coil loop; and a plurality of wires coupling each coupling electronics unit to an interface board configured to couple to a cable of the MRI system. The RF coil array is a high density (referring to the number of coil elements) anterior array (HDAA) or a high definition (referring to image resolution) anterior array.Filed by GE Precision Healthcare LLC; granted 2021-02-16.


| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6701176B1 | Magnetic-resonance-guided imaging, electrophysiology, and ablation | 530 |
| 2 | US20050054910A1 | Optical image-based position tracking for magnetic resonance imaging applications | 447 |
| 3 | US5560360A | Image neurography and diffusion anisotropy imaging | 420 |
| 4 | US6198957B1 | Radiotherapy machine including magnetic resonance imaging system | 405 |
| 5 | US6628980B2 | Apparatus, systems, and methods for in vivo magnetic resonance imaging | 403 |
| 6 | US8812077B2 | System and method for image guidance during medical procedures | 343 |
| 7 | US20140364720A1 | Systems and methods for interactive magnetic resonance imaging | 310 |
| 8 | US6246896B1 | MRI guided ablation system | 297 |
| 9 | US20130063143A1 | Local SAR Constrained Parallel Transmission RF Pulse in Magnetic Resonance Imaging | 287 |
| 10 | US5752515A | Methods and apparatus for image-guided ultrasound delivery of compounds through the blood-brain barrier | 271 |
Ranked by citation count within the searched corpus; older records tend to rank higher because they have had more time to accumulate citations.
Each row carries its publication number; clicking a row searches Eureka by that number.
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Volume, citation and momentum data together describe a technology area that is heavily claimed at its core and slowing in fresh activity, with a few narrow branches still open.
Filings ran at 623 in 2017, peaked at 670 in 2019, and had already fallen to 492 by the 2022 midpoint. The drop to 26 by 2026 partly reflects publication lag, but the multi-year decline before that is a genuine slowdown in fresh filing.
G01R (electric and magnetic measurement) and A61B (diagnosis and surgery) together account for the large majority of records, meaning most scanner hardware and diagnostic integration territory is already densely filed.
The five most-cited records, including US6701176B1 on MR-guided ablation and US5560360A on diffusion anisotropy imaging, anchor much of the field's later filing. High citation counts here reflect foundational status within the corpus, not current relevance.
Several long-standing assignees, including Philips and Shanghai United Imaging, show sharp year-over-year declines or zero filings in the latest year, consistent with the broader flattening trend rather than isolated to one company.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to medical imaging mri landscape, with the prior art for and against each one.
Ownership in this dataset is concentrated among established medical imaging manufacturers, several of which file through linked parent-subsidiary structures, while recent-year momentum shows even the largest filers pulling back sharply.
The strongest co-assignee pairing in the dataset links Toshiba and Toshiba Medical Systems across 575 shared families, far ahead of the next pairing, Philips and Philips Intellectual Property & Standards at 93. Treating parent and subsidiary as one filer changes the effective concentration at the top.
Philips shows only 1 filing in the latest year, down 96% year-over-year, and Shanghai United Imaging shows a similar pattern at -75%. Toshiba, GE and Hitachi Medical show zero filings in the latest year in this cut, though the partial final year understates true activity.
The Samsung Electronics and Korea Advanced Institute of Science and Technology (KAIST) pairing, with 41 shared families, shows that not all consolidation is between corporate parent and subsidiary; some reflects sustained university-industry collaboration on MRI-related technology.
| Assignee | Recent year | YoY |
|---|---|---|
| Koninklijke Philips N.V. (Royal Philips) | 1 | -96% |
| Shanghai United Imaging Healthcare Co., Ltd. | 1 | -75% |
| Toshiba Corporation | 0 | — |
| Toshiba Medical Systems Corporation | 0 | — |
| General Electric Company | 0 | — |
| Hitachi Medical Corporation | 0 | — |
| Samsung Electronics Co., Ltd. | 0 | — |
| GE Medical Systems Global Technology Company, LLC | 0 | — |
The dataset points to specific follow-up questions depending on whether the goal is freedom-to-operate, white space identification, or competitive tracking.
The five most-cited patents, including US6701176B1 and US6198957B1, anchor much of the surrounding claim space. Any new RF coil, reconstruction or MR-guided system design should be checked against these specifically before broader searching.
Run a claim comparison in EurekaWith Toshiba, Philips and Shanghai United Imaging all showing flat or declining recent-year activity, monitoring which assignee resumes filing first is a useful early signal of where competitive investment is shifting.
Set up assignee tracking in EurekaG01N, H01F and A61N carry a fraction of the volume of the core subclasses. A targeted prior-art search in these areas before drafting is likely to surface less entrenched positions than in G01R or A61B.
Search white space in EurekaFiling activity in this dataset is concentrated among a handful of large medical imaging manufacturers whose portfolios include long-running RF coil, gradient coil and reconstruction filings. Corporate structures matter here: several of the top holders operate through linked entities, such as the Toshiba and Toshiba Medical Systems pairing that shares 575 families. Rather than a single dominant assignee, the picture is a concentrated top group followed by a long tail of smaller filers, so checking both a parent company and its medical-systems subsidiary is necessary for a complete picture.
No. Filings peaked at 670 in 2019, sat at 623 in 2017, and had fallen to 492 by the 2022 midpoint before dropping further toward 26 in 2026. That trajectory is flat to declining rather than growing, though the most recent one to two years will always look artificially low because publication typically lags filing by about 18 months. The honest read is a mature filing base rather than an expanding one.
G01R (electric and magnetic measurement) and A61B (diagnosis and surgery) carry the bulk of the record volume, at 10,752 and 7,403 respectively, and between them define the core claim space for scanner hardware and diagnostic system integration. G06T (image data processing) is a smaller but distinct layer covering reconstruction and acceleration software. Smaller subclasses like A61N, H01F, G06N and G01N mark adjacent or emerging areas rather than core territory.
US10921401B2, granted 2021-02-16 to GE Precision Healthcare LLC, covers a flexible, lightweight anterior RF coil array for MRI systems built from coil loops with integrated capacitors, per-loop coupling electronics, and a shared interface board, described as a high-density or high-definition anterior array. It is a hardware-level coil claim rather than a broad system claim, so its blocking effect is specific to that coil architecture rather than to RF coil arrays in general. Anyone designing a competing anterior array should check this claim combination specifically rather than assuming general freedom to operate in coil design.
The thinnest filed categories relative to the core G01R and A61B volumes are material analysis integration (G01N, 321 records), magnet and inductor hardware (H01F, 404 records) and electrotherapy-linked MRI (A61N, 472 records). These are areas where claim density is low rather than technically impossible, which is a meaningfully different signal than a crowded field. Recent-year momentum also shows several established filers, including Philips, pulling back sharply, which can create room for new claims even in adjacent core areas.
Go past this page: query the whole medical imaging mri landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.